Advertisement

Topics

Cellectis Group Company Profile

06:24 EDT 23rd March 2019 | BioPortfolio

Cellectis stem cells, is a business unit within the Cellectis group and is a global leader in stem cell technology. Cellectis stem cells, created in November 2011 from Cellartis AB and Ectycell SAS, possesses broad expertise in pluripotent stem cells, including iPS cell technology, genetic engineering and specialised cells. Cellectis stem cells is developing stem cell derived products and related services for drug discovery, toxicity testing and regenerative medicine applications.


News Articles [727 Associated News Articles listed on BioPortfolio]

Cellectis to build CAR-T manufacturing sites in US and Europe

In a step towards the commercialisation of its âoff-the-shelfâ CAR-T therapies, Cellectis begins construction of a facility in France and enters lease agreement for US facility.

Cellectis: Monthly Information on Share Capital and Company Voting Rights

(Article 223-16 of General Regulation of the French financial markets authority) Regulatory News: Cellectis (Paris:ALCLS) (NASDAQ:CLLS): Listing market: Euronext Growth ISIN code: FR0010425595 Dat...

Cellectis in offering of US$175m ADS following asset swap

AML: Cellectis testing allogenic CAR-T cell therapy

Cellectis (CLLS) Presents At Barclays Global Healthcare Conference - Slideshow

Cellectis S.A. (CLLS) To Present At Oppenheimer 29th Annual Healthcare Conference - Slideshow

Speed of execution in the CAR-T space on a relative basis. Novartis Kite | | | | | | Juno | | | | | | | | | | | | | | | | | | | | | | | | Cellectis | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Bellicum

Speed of execution in the CAR-T space on a relative basis. Novartis Kite | | | | | | Juno | | | | | | | | | | | | | | | | | | | | | | | | Cellectis | | | | | | | | | | | | | | | | | | | | | | | | | |...

Cellectis to Build Mfg. Facility in North Carolina

With help from CMO partners, advances further towards commercialization of UCART portfolio

Drugs and Medications [0 Results]

None

PubMed Articles [1688 Associated PubMed Articles listed on BioPortfolio]

Isolation and exploitation of minority: Game theoretical analysis.

We investigate various group-size distributions occurring in a situation where each group's resource is exposed to appropriation by other groups. The amount of appropriation depends on the size differ...

Life sciences licensing deals in the second quarter of 2018: updates and trends.

During the second quarter of 2018, Cortellis Competitive Intelligence registered 985 new deals (excluding mergers and acquisitions) with a total disclosed deal value of USD 19.5 billion as part of its...

Reply to readers (Manuscript ID: HEP-18-1297).

In our preliminary experiment, we divided patients into 3 groups, 10 patients in each group. Group A received standard medicine treatment (SMT) only. Group B was treated with allogeneic bone marrow-de...

Characteristics of 2017 GOLD COPD group A: a multicenter cross-sectional CAP study in Japan.

The 2017 GOLD ABCD classification shifts patients from groups C-D to A-B. Group A was the most widely distributed group in several studies. It would be useful to understand the characteristics for gro...

Appearance of large scavenger receptor A-positive cells in peripheral blood: A potential risk factor for severe exacerbation of chronic obstructive pulmonary disease.

Fresh peripheral blood (PB) samples from 432 outpatients with stable chronic obstructive pulmonary disease (COPD) were examined. Patients were classified into Group A (large SRA cells were undetected)...

Clinical Trials [4373 Associated Clinical Trials listed on BioPortfolio]

MAC-cbt Group Therapy for Adults With ADHD

The study is developed to validate a new short psychotherapeutic group treatment for adults with ADHD diagnosis. The participants will be treated in a monocentric, parallel group randomize...

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Ultrasound and Exercises in Knee Osteoarthritis

The aim of this investigation is to compare the effects of continuous (CUS) and pulsed (PUS) ultrasound associated with a program of exercises on pain, range of motion, muscle strength, fu...

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Companies [1661 Associated Companies listed on BioPortfolio]

Cellectis Group

Cellectis stem cells, is a business unit within the Cellectis group and is a global leader in stem cell technology. Cellectis stem cells, created in November 2011 from Cellartis A...

Cellectis

Cellectis is a pioneer in the field of genome engineering. The company designs and markets innovative tools, meganucleases. These molecular scissors enable targeted modifications ...

Cellectis bioresearch

Cellectis bioresearch was incorporated as a subsidiary of Cellectis SA (Alternext: ALCLS) in June 2008. It provides life science researchers with ready-to-use research tools for genome customization. ...

Cellectis S.A.

Cellectis S.A. is a world leader in genome engineering and genome surgery. The company focuses on developing and producing custom meganucleases for use in in vivo genome surgery a...

Cellectis therapeutics

Cellectis is a pioneer in the field of genome engineering. The company designs and markets innovative tools -meganucleases. These molecular scissors enable targeted modifications to DNA, with applicat...

More Information about "Cellectis Group" on BioPortfolio

We have published hundreds of Cellectis Group news stories on BioPortfolio along with dozens of Cellectis Group Clinical Trials and PubMed Articles about Cellectis Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cellectis Group Companies in our database. You can also find out about relevant Cellectis Group Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record